Press Releases

Press Releases

LEXINGTON, MA – November 17, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that the paper, “
March 1, 2016
Quanterix announces that it has been selected by Fast Company as one of the world’s top 10 most innovative companies in 2016 in Sports – the only medical technology company to be recognized in this category.
September 26, 2016
Quanterix announces that it is making a strategic investment in ImmunArray, a molecular diagnostics company advancing the development of novel, multi-marker tests for complex diseases with compelling levels of accuracy.
Discussion to be led by Cedars-Sinai Medical Center Professor of Medicine Dr. Jennifer E. Van Eyk
Quanterix is sponsoring a webinar by Dr. Jennifer E. Van Eyk, professor of medicine, Cedars-Sinai Medical Center, on the need for precise protein quantification and identification in personalized medicine on Tuesday, April 18, 2017 from 1:00 – 2:00 p.m. EST.
July 18, 2017
Dr. Daniel Sikkema joins Quanterix as Vice President of Accelerator Services to lead the growth of the company’s contract research lab and support precision health advances across a wide range of therapeutic categories
CAMBRIDGE, MA – November 11, 2008 – Quanterix Corporation, the leader in single molecule detection, announced today that Robert Corn, Ph.D. has joined its Scientific Advisory Board (SAB). Dr. Corn is a Professor in the Departments of Chemistry and Biomedical Engineering at the University of…

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more